prikaz prve stranice dokumenta Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
  Download
PDF 2.84 MB
Scientific paper - Chapter in Book
Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
In: Updates on Renal Replacement Therapy / H.L. Wu, Henry (Ed.). IntechOpen, 2024. pp. 1-33. https://doi.org/10.5772/intechopen.114022
Vujičić, Božidar; Benko, Koraljka; Petretić, Ana; Nemarnik, Nenad; Spicijarić, Matko; Markić, Dean; Bura, Matej; Kadum, Fabio; Rački, Sanjin; Ružić, Alen

Cite this document

Vujičić, B., Benko, K., Petretić, A., Nemarnik, N., Spicijarić, M., Markić, D. ... Ružić, A. (2024). Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease. In H. H.L. Wu, (Ed.), Updates on Renal Replacement Therapy (pp. 1-33). IntechOpen. doi: 10.5772/intechopen.114022

Vujičić, Božidar, et al. "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease." Updates on Renal Replacement Therapy, edited by Henry H.L. Wu, IntechOpen, 2024, pp. 1-33. https://urn.nsk.hr/urn:nbn:hr:184:831438

Vujičić, Božidar, Koraljka Benko, Ana Petretić, Nenad Nemarnik, Matko Spicijarić, Dean Markić, Matej Bura, Fabio Kadum, Sanjin Rački and Alen Ružić. "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease." In Updates on Renal Replacement Therapy, edited by Henry H.L. Wu, 1-33. IntechOpen, 2024. https://urn.nsk.hr/urn:nbn:hr:184:831438

Vujičić, B., et al. (2024) 'Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease' in H.L. Wu, H. (ed.) Updates on Renal Replacement Therapy IntechOpen, pp. 1-33. Available at: https://urn.nsk.hr/urn:nbn:hr:184:831438 (Accessed 20 August 2024)

Vujičić B, Benko K, Petretić A, Nemarnik N, Spicijarić M, Markić D, and sur.. Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease. In: H. H.L. Wu, ed. Updates on Renal Replacement Therapy. IntechOpen; 2024. Pp. 1-33. [cited 2024 August 20] Available at: https://urn.nsk.hr/urn:nbn:hr:184:831438

B. Vujičić, et al., "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease", Updates on Renal Replacement Therapy, H. H.L. Wu, Ed. IntechOpen, 2024, pp. 1-33. [Online] Available at: https://urn.nsk.hr/urn:nbn:hr:184:831438

Please login to the repository to save this object to your list.
Metadata
Title (english)Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
AuthorBožidar Vujičić
AuthorKoraljka Benko
AuthorAna Petretić
AuthorNenad Nemarnik
AuthorMatko Spicijarić
AuthorDean Markić
AuthorMatej Bura
AuthorFabio Kadum
AuthorSanjin Rački
AuthorAlen Ružić
EditorHenry H.L. Wu
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Urology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Urology
Abstract (croatian)
In patients with Congestive Heart Failure (CHF), neurohormonal activation leads to fluid overload that can be treated with high doses of furosemide unless diuretic resistance and hyponatremia develop. End-stage CHF, including patients with normal or slightly deteriorated kidney function, can resist medical treatment. In some cases of refractory CHF, ultrafiltration (UF) is required. To manage a refractory CHF population, extracorporeal UF is commonly used as an emergency treatment, but peritoneal UF should be considered a follow-up therapy option. This method offers potential advantages over extracorporeal therapies, including better preservation of residual renal function, tighter control of sodium balance, less neurohumoral activation, and the possibility of daily treatment in the home environment. Using glucose as an osmotic agent leads to the deterioration of the peritoneal membrane. The UF properties of icodextrin depend on the dwell time, whereby the maximum effect of icodextrin concerning glucose is achieved at a prolonged dwell time. Icodextrin may offer improved peritoneal membrane biocompatibility compared with conventional glucose-based dialysates by decreasing glucose exposure, iso-osmolarity, and reduced carbonyl stress. The proper anesthesia technique and surgical approach for peritoneal dialysis (PD) catheter placement in CHF patients must be based on the patient’s characteristics, available equipment, and surgeon’s experience. An open procedure using a transversus abdominis plane block for PD catheter placement in patients with CHF is strongly recommended.
Keywords (english)
Languageenglish
Publication typeScientific paper - Chapter in Book
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Book titleUpdates on Renal Replacement Therapy
Numberingpp. 1-33
ISBN978-1-83769-175-3 (online)
ISBN978-1-83769-174-6 (print)
DOIhttps://doi.org/10.5772/intechopen.114022
URN:NBNurn:nbn:hr:184:831438
Publication2024-01-31
Document URLhttps://www.intechopen.com/chapters/88870
Type of resourceText
PublisherIntechOpen
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2024-08-16 06:46:47